All Stories

  1. Metabolic activation and cytotoxicity of metaxalone mediated by cytochrome P450 enzymes and sulfotransferases
  2. Evidence for the Metabolic Activation of Deferasirox In Vitro and In Vivo
  3. Recent advances in mass spectrometry-based spatially resolved molecular imaging of drug disposition and metabolomics
  4. Difference in hepatotoxicity of furan-containing components in cortex dictamni correlates the efficiency of their metabolic activation
  5. Reduction of emodin-8-O-ß-D-glucoside content participates in processing-based detoxification of polygoni multiflori radix
  6. DNA damage and up-regulation of PARP-1 induced by columbin in vitro and in vivo
  7. Formation of RNA adducts resulting from metabolic activation of spice ingredient safrole mediated by P450 enzymes and sulfotransferases
  8. Immunochemical and LC–MS/MS Detection of Protein Adduction Resulting from Metabolic Activation of Columbin In Vitro and In Vivo
  9. Mechanistic Study of Xanthotoxin-Mediated Inactivation of CYP1A2 and Related Drug–Drug Interaction with Tacrine
  10. Effects of xenobiotics on CYP1 enzyme-mediated biotransformation and bioactivation of estradiol
  11. OAT3 Participates in Drug–Drug Interaction between Bentysrepinine and Entecavir through Interactions with M8—A Metabolite of Bentysrepinine—In Rats and Humans In Vitro
  12. In Vitro and In Vivo Metabolic Activation of Tolterodine Mediated by CYP3A
  13. Inflammation Intensifies Monocrotaline-Induced Liver Injury
  14. Quinoline is more genotoxic than 4-methylquinoline in hiHeps cells and rodent liver
  15. Metabolic Activation of Pesticide Isoprocarb Mediated by CYP3A4 and the Possible Correlation with Its Cytotoxicity
  16. Evaluating and predicting the correlations of hepatic concentration and pyrrole-protein adduction with hepatotoxicity induced by retrorsine based on pharmacokinetic/pharmacodynamic model
  17. Configurational Alteration Results in Change in Hepatotoxicity of Asarone
  18. 2,3,5,4′-Tetrahydroxy stilbene-2-Ο-β-D-glucoside, a mechanism-based inactivator of CYP2C19 and CYP3A4, potentiates hepatic protein adduction and hepatotoxicity induced by emodin in vivo
  19. Diverse sesquiterpenoids from Litsea lancilimba Merr. with potential neuroprotective effects against H2O2-induced SH-SY5Y cell injury
  20. Hepatic RNA adduction derived from metabolic activation of retrorsine in vitro and in vivo
  21. Evidence for Metabolic Activation of Omeprazole In Vitro and In Vivo
  22. Asparagine and Glutamine Residues Participate in Protein Covalent Binding by Epoxide Metabolite of 8-Epidiosbulbin E Acetate In Vitro and In Vivo
  23. Evidence for adduction of biologic amines with reactive metabolite of 8-epidiosbulbin E acetate in vitro and in vivo
  24. Diosbulbin B: An important component responsible for hepatotoxicity and protein covalent binding induced by Dioscorea bulbifera L.
  25. Development of a mechanism-based biomarker for Dioscorea bulbifera L. exposure and hepatotoxicity in rats
  26. Metabolic Activation of Gemfibrozil Mediated by Cytochrome P450 Enzymes and Sulfotransferases
  27. Phytochemistry, synthesis, analytical methods, pharmacological activity, and pharmacokinetics of loganin: A comprehensive review
  28. In Vitro and In Vivo Metabolic Activation and Hepatotoxicity of Environmental Pollutant 2,6-Dimethylphenol
  29. Identification of Metoprolol Tartrate-Derived Reactive Metabolites Possibly Correlated with Its Cytotoxicity
  30. DNA damage by reactive oxygen species resulting from metabolic activation of 8-epidiosbulbin E acetate in vitro and in vivo
  31. Metabolic activation of 3-aminodibenzofuran mediated by P450 enzymes and sulfotransferases
  32. Metabolic Activation of Militarine In Vitro and In Vivo
  33. Metabolic Activation and Cytotoxicity of Propafenone Mediated by CYP2D6
  34. Anastrozole and related glucuronic acid conjugate are electrophilic species
  35. 2-Naphthalenemethanol participates in metabolic activation of 2-methylnaphthalene
  36. Small Molecule Accurate Recognition Technology accelerated isolation of structurally diverse sesquiterpenes from Litsea lancilimba Merr.
  37. A Metabolic Activation-Based Chemoproteomic Platform to Profile Adducted Proteins Derived from Furan-Containing Compounds
  38. Metabolic Activation and Cytotoxicity of Fungicide Carbendazim Mediated by CYP1A2
  39. Response to the comments raised by Fernando Tricta
  40. Metabolic Activation of Perampanel Mediated by CYP1A2
  41. Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A
  42. Metabolic Activation and Hepatotoxicity of Furan-Containing Compounds
  43. Cysteine-Based Protein Covalent Binding and Hepatotoxicity Induced by Emodin
  44. RNA adduction derived from electrophilic species in vitro and in vivo
  45. Amino Acid and Biogenic Amine Adductions Derived from Reactive Metabolites
  46. Toxicokinetic and bioavailability studies on retrorsine in mice, and ketoconazole‐induced alteration in toxicokinetic properties
  47. Glutathione conjugation and protein modification resulting from metabolic activation of venlafaxine in vitro and in vivo
  48. Metabolic activation of zolmitriptan mediated by CYP2D6
  49. Metabolic activation of aegeline mediated by CYP2C19
  50. Metabolic activation of deferiprone mediated by CYP2A6
  51. Oxypeucedanin is a Mechanism-based Inactivator of CYP2B6 and CYP2D6
  52. Metabolic Activation of Atomoxetine Mediated by Cytochrome P450 2D6
  53. Icotinib Induces Mechanism-Based Inactivation of Recombinant Human CYP3A4/5 Possibly via Heme Destruction by Ketene Intermediate
  54. Mechanistic study of bergamottin-induced inactivation of CYP2C9
  55. Metabolic Activation and Cytotoxicity of Labetalol Hydrochloride Mediated by Sulfotransferases
  56. Reversible and Irreversible Inhibition of Cytochrome P450 Enzymes by Methylophiopogonanone A
  57. In Vitro and In Vivo Evidence for RNA Adduction Resulting from Metabolic Activation of Methyleugenol
  58. An LC-MS/MS- and hURAT1 cell-based approach for screening of uricosuric agents
  59. Antibody-based detection of lysine modification of hepatic protein in mice treated with retrorsine
  60. Identification, synthesis and structural confirmation of process-related impurities in proparacaine hydrochloride
  61. Glutathione Conjugation and Protein Adduction by Environmental Pollutant 2,4-Dichlorophenol In Vitro and In Vivo
  62. Dioscorea bulbifera L.-induced hepatotoxicity and involvement of metabolic activation of furanoterpenoids
  63. Metabolic Activation of Pirfenidone Mediated by Cytochrome P450s and Sulfotransferases
  64. Evidence for Polyamine, Biogenic Amine, and Amino Acid Adduction Resulting from Metabolic Activation of Diosbulbin B
  65. Reply to Letter to Editor from Veeravalli and Dash on “Tofacitinib Is a Mechanism-Based Inactivator of Cytochrome P450 3A4: Revisiting the Significance of the Epoxide Intermediate and Glutathione Trapping”
  66. Mechanism-based inactivation of cytochrome P450 2D6 by Notopterol
  67. Immunochemical Detection of Protein Modification Derived from Metabolic Activation of 8-Epidiosbulbin E Acetate
  68. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin
  69. Synthesis, bioconversion, pharmacokinetic and pharmacodynamic evaluation of N-isopropyl-oxy-carbonyloxymethyl prodrugs of CZh-226, a potent and selective PAK4 inhibitor
  70. Piperine Is a Mechanism-Based Inactivator of CYP3A
  71. Metabolic Activation of Tofacitinib Mediated by Myeloperoxidase in Vitro
  72. Glutathione Conjugation and Protein Adduction Derived from Oxidative Debromination of Benzbromarone in Mice
  73. In vitro and in vivo studies of the metabolic activation of chelidonine
  74. Studies on hepatotoxicity and toxicokinetics of colchicine
  75. Nitidine Chloride–Induced CYP1 Enzyme Inhibition and Alteration of Estradiol Metabolism
  76. Identification of Quinone Methide Intermediate Resulting from Metabolic Activation of Icaritin in Vitro and in Vivo
  77. Sex difference in monocrotaline-induced developmental toxicity and fetal hepatotoxicity in rats
  78. Prenatal exposure to pyrrolizidine alkaloids induced hepatotoxicity and pulmonary injury in fetal rats
  79. Metabolism‐based herb–drug interaction ofCorydalis Bungeanae Herbawith berberinein vitroandin vivoin rats
  80. Chemical Reactivity of Aloe-Emodin and Its Hydroxylation Metabolites to Thiols
  81. In Vitro DNA Adduction Resulting from Metabolic Activation of Diosbulbin B and 8-Epidiosbulbin E Acetate
  82. Characterization of glutathione conjugates derived from reactive metabolites of seven silymarin isomers
  83. A Difference in Internal Exposure Makes Newly Weaned Mice More Susceptible to the Hepatotoxicity of Retrorsine Than Adult Mice
  84. Cytochrome P450 mediated metabolic activation of chrysophanol
  85. Nitidine Chloride Is a Mechanism-Based Inactivator of CYP2D6
  86. In Vitro and in Vivo Studies of the Electrophilicity of Physcion and its Oxidative Metabolites
  87. Development of Polyclonal Antibodies for Detection of Diosbulbin B-Derived cis-Enedial Protein Adducts
  88. Urinary Methyleugenol-deoxyadenosine Adduct as a Potential Biomarker of Methyleugenol Exposure in Rats
  89. Maternal-Fetal Disposition and Metabolism of Retrorsine in Pregnant Rats
  90. Identification of Ketene-Reactive Intermediate of Erlotinib Possibly Responsible for Inactivation of P450 Enzymes
  91. Metabolic Epoxidation Is a Critical Step for the Development of Benzbromarone-Induced Hepatotoxicity
  92. Metabolite profile analysis and pharmacokinetic study of emodin, baicalin and geniposide in rats
  93. Chemical Identity of Interaction of Protein with Reactive Metabolite of Diosbulbin B In Vitro and In Vivo
  94. Pharmacokinetic comparison of two phenolic acids after oral administration of Typhae pollen to normal rats and rats with acute cold blood stasis
  95. Sensitive bromine-based screening of potential toxic furanoids in Dioscorea bulbifera L.
  96. Immunoassay approach for diagnosis of exposure to pyrrolizidine alkaloids
  97. Chemical Interaction of Protein Cysteine Residues with Reactive Metabolites of Methyleugenol
  98. Comparative Study of Hepatotoxicity of Pyrrolizidine Alkaloids Retrorsine and Monocrotaline
  99. Lysine- and cysteine-based protein adductions derived from toxic metabolites of 8-epidiosbulbin E acetate
  100. In vitro and in vivo metabolic activation of berbamine to quinone methide intermediate
  101. Cytochrome P450 Mediated Bioactivation of Saracatinib
  102. Simultaneous assessment of endogenous thiol compounds by LC–MS/MS
  103. Identification of glutathione and related cysteine conjugates derived from reactive metabolites of methyleugenol in rats
  104. Oxidative bioactivation of nitrofurantoin in rat liver microsomes
  105. Detection of protein adduction derived from dauricine by alkaline permethylation
  106. Design, synthesis and biological evaluation of N,N-3-phenyl-3-benzylaminopropanamide derivatives as novel cholesteryl ester transfer protein inhibitor
  107. Role of Metabolic Activation in 8-Epidiosbulbin E Acetate-Induced Liver Injury: Mechanism of Action of the Hepatotoxic Furanoid
  108. 9-Glutathionyl-6,7-dihydro-1-hydroxymethyl-5H-pyrrolizine Is the Major Pyrrolic Glutathione Conjugate of Retronecine-Type Pyrrolizidine Alkaloids in Liver Microsomes and in Rats
  109. Identification of Epoxide-Derived Metabolite(s) of Benzbromarone
  110. Characterization of glutathione conjugates derived from reactive metabolites of bakuchiol
  111. Homoharringtonine binds to and increases myosin-9 in myeloid leukaemia
  112. Detection of cysteine- and lysine-based protein adductions by reactive metabolites of 2,5-dimethylfuran
  113. Psoralen, a mechanism-based inactivator of CYP2B6
  114. Blood Pyrrole-Protein Adducts—A Biomarker of Pyrrolizidine Alkaloid-Induced Liver Injury in Humans
  115. CYP3A5 mediates bioactivation and cytotoxicity of tetrandrine
  116. Mechanism-based inactivation of cytochrome P450 2B6 by isopsoralen
  117. In Vitro and In Vivo Characterization of Reactive Intermediates of Corynoline
  118. Comparative studies of pharmacokinetics and anticoagulatory effect in rats after oral administration of Frankincense and its processed products
  119. Mechanism-based inactivation of CYP2C9 by linderane
  120. Mass spectrometry based detection of glutathione with sensitivity for single-cell analysis
  121. Metabolic activation of furan moiety makes Diosbulbin B hepatotoxic
  122. Mechanism-based inactivation of cytochrome P450 2B6 by isoimperatorin
  123. N-Acetyl Lysine/Glutathione-Derived Pyrroles as Potential Ex Vivo Biomarkers of Bioactivated Furan-Containing Compounds
  124. Imperatorin Is a Mechanism-Based Inactivator of CYP2B6
  125. Selective and Sensitive Platform for Function-Based Screening of Potentially Harmful Furans
  126. Cytochrome P450–Mediated Metabolic Activation of Diosbulbin B